Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Posted on by ScienceFather

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8

 

 

 

Prof. Dr. Meltem Muftuoglu | Drug delivery Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Meltem Muftuoglu | Drug delivery Awards | Best Researcher Award

Prof. Dr. Meltem Muftuoglu, Acibadem Mehmet Ali Aydinlar University, Turkey

Professor Meltem Muftuoglu is a distinguished molecular biologist and biochemist based at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey. She holds dual professorships in the Departments of Molecular Biology and Genetics and Medical Biotechnology. Prof. Muftuoglu earned her Ph.D. in Biochemistry from Hacettepe University and has extensive research experience in molecular genetics and cellular medicine, including postdoctoral work at the NIH’s National Institute on Aging. Her work focuses on cancer drug delivery, mitochondrial targeting therapies, and DNA repair mechanisms, with numerous peer-reviewed publications in high-impact journals. An NIH and NATO A2 Scholar, she has received various awards, reflecting her significant contributions to biochemistry and molecular biology.

Professional Profile:

Scopus

Orcid

Suitability for the Best Researcher Award: Professor Meltem Muftuoglu

Summary of Suitability:

Professor Meltem Muftuoglu’s extensive academic and research career makes her an exemplary candidate for the Best Researcher Award. Her tenure at leading institutions, including her current professorship at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, underscores her commitment to advancing knowledge in molecular biology and medical biotechnology.

🎓Education:

Professor Meltem Muftuoglu holds a comprehensive academic background in biochemistry and biological sciences. She earned her B.Sc. in Biological Sciences in 1991 from Middle East Technical University in Ankara, Turkey. She then pursued graduate studies at Hacettepe University, Faculty of Medicine, where she completed an M.Sc. in Biochemistry in 1995 and subsequently a Ph.D. in Biochemistry in 2001. Recognized for her expertise, she received a docent degree in Biochemistry from the Higher Education Council in Ankara in 2005. Since 2015, Professor Muftuoglu has served as a Professor at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, where she contributes significantly to the fields of molecular biology and biotechnology.

🏢Work Experience:

Professor Meltem Muftuoglu has an extensive career in academia and research, marked by key positions across leading institutions worldwide. Since 2015, she has held a professorship at the Department of Molecular Biology and Genetics at Acibadem Mehmet Ali Aydinlar University in Istanbul, Turkey, and since 2018, she has also been a professor in the university’s Department of Medical Biotechnology. Prior to these roles, she served as an Associate Professor at the same university in Molecular Biology and Genetics (2014–2015) and at Koc University’s School of Medicine in the Department of Biochemistry (2011–2014). From 2009 to 2011, she was an Assistant Professor at the University of Copenhagen’s Department of Cellular and Molecular Medicine. Her research journey also includes a prestigious postdoctoral fellowship at the Laboratory of Molecular Gerontology, National Institute on Aging (NIH), in the United States (2004–2009). Additionally, she has served as an Assistant Professor in the Department of Biochemistry at Hacettepe University in Ankara, Turkey (2001–2004), and as a Research Scholar in the Laboratory of Molecular Genetics at the NIH’s National Institute on Aging (1999–2000). Earlier in her career, she was a Teaching and Research Assistant in Biochemistry at Hacettepe University (1993–2001), establishing a strong foundation for her distinguished work in biochemistry and molecular biology.

🏅Awards and Scholarships:

Throughout her career, Professor Meltem Muftuoglu has been recognized with numerous prestigious awards that highlight her contributions and commitment to scientific research. From 2004 to 2009, she was honored with the NIH Ruth L. Kirschstein National Research Service Award (NRSA), underscoring her excellence in research at the National Institute on Aging. In 2005, she was celebrated at the International Academy of Achievement Summit, reflecting her notable achievements in the field. Earlier, she was awarded the NATO A2 Scholarship by the Scientific and Technical Research Council of Turkey in 1998, and during 1999–2000, she received the NIH Fogarty Scholarship, further affirming her dedication to advancing biochemistry and molecular biology on a global scale.

🔬Research Focus:

Professor Muftuoglu’s research centers on advancing cancer therapeutics, mitochondrial targeting, and understanding DNA repair mechanisms. Her work in cancer drug delivery focuses on developing novel methods, including hydrophobin-coated and mitochondria-targeted liposomes, for more efficient and precise drug delivery to cancer cells. She is also exploring mitochondrial targeting therapies, which seek to selectively deliver drugs to mitochondria, enhancing both the efficacy and specificity of cancer treatments. Additionally, Professor Muftuoglu investigates DNA repair mechanisms, particularly base excision repair pathways, to uncover genetic factors that impact diseases like Alzheimer’s and various cancers.

Publication Top Notes:

  • Cosmic Whirl: Navigating the Comet Trail in DNA: H2AX Phosphorylation and the Enigma of Uncertain Significance Variants
  • Formulation Development and Evaluation of Fluvastatin Loaded Transethosomes: Characterization, Stability, In Vitro Dermal Penetration, Cytotoxicity and Antipsoriatic Activity Studies
    • Citations: 1
  • Targeting Mitochondrial DNA Polymerase Gamma for Selective Inhibition of MLH1 Deficient Colon Cancer Growth
    • Citations: 8
  • Leukocyte Telomere Length as a Compensatory Mechanism in Vitamin D Metabolism
    • Citations: 3
  • Parents of Ataxia-Telangiectasia Patients Display a Distinct Cellular Immune Phenotype Mimicking ATM-Mutated Patients
    • Citations: 5

 

 

 

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Posted on by ScienceFather

Prof. Franciska Erdo | Drug delivery Award | Best Researcher Award

Prof. Franciska Erdo , Pázmány Péter Catholic University , Hungary

Franciska Vidáné Dr. Erdő, born on May 28, 1964, in Budapest, is a distinguished full professor and lab head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. She holds a PhD in pharmacology from Semmelweis University and has extensive experience in both academic and research institutions, including the University of Tours, Charité Medizinische Universität in Berlin, and the Max-Planck Institute in Cologne. Her research focuses on drug research and development, evidenced by her numerous fellowships and scholarships. She has supervised over 31 graduate students and postdoctoral fellows and has been recognized for her teaching excellence. Dr. Erdő has also contributed significantly to scientific literature and education, particularly in the fields of molecular bionics and biomedical innovation.

Professional Profile:

Orcid

Education:

Franciska Vidáné Dr. Erdő earned her MSc in Pharmacy from Semmelweis University in 1987, graduating with top grades. She continued her education at the same institution, achieving a University Doctor degree in Pharmacology with summa cum laude honors in 1994. In 1997, she completed her PhD in Pharmacology, also with summa cum laude distinction, at Semmelweis University, Faculty of Pharmacy. Most recently, in 2019, she received her habilitation from Pázmány Péter Catholic University, Faculty of Information Technology and Bionics.

Work Experience:

Franciska Vidáné Dr. Erdő has held numerous esteemed positions throughout her career. Since 2024, she has been serving as a Full Professor and Lab Head at Pázmány Péter Catholic University, Faculty of Information Technology and Bionics. Prior to this, from 2019 to 2024, she was an Associate Professor and Lab Head at the same institution. She was also a Guest Researcher at the University of Tours, France, in 2022. From 2014 to 2019, she worked as a Senior Research Fellow and Lab Head at Pázmány Péter Catholic University. Her earlier roles include serving as a Senior Research Fellow and Lab Head at SOLVO Biotechnology from 2007 to 2014, and holding a scientific scholarship at Charité Medizinische Universität in Berlin, Germany, from 2005 to 2006. She also worked as a Senior Research Fellow at IVAX Drug Research Institute from 2003 to 2007 and held a Max Planck Fellowship at the Max-Planck Institute für neurologische Forschung in Cologne, Germany, from 2000 to 2003. Her earlier positions include Senior Research Fellow roles at Sanofi-Synthelabo Chinoin from 1997 to 2000 and Biorex R&D Co. from 1995 to 1997. She began her career as a Research Fellow at the Institute for Drug Research from 1990 to 1995 and as a Junior Research Fellow at the same institute from 1987 to 1990.

Publication Top Notes:

1.Fluid Dynamics Optimization of Microfluidic Diffusion Systems for Assessment of Transdermal Drug Delivery: An Experimental and Simulation Study

  • Journal: Scientia Pharmaceutica
  • Publication Date: June 2024

2. Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations

  • Journal: Pharmaceutics
  • Publication Date: June 2024

3. Transdermal Delivery of α-Aminophosphonates as Semisolid Formulations—An In Vitro-Ex Vivo Study

  • Journal: Pharmaceutics
  • Publication Date: May 2023